Quick Answer
Elevance Health, Inc. reported Total Revenue of $199.12 billion for fiscal year 2025.
Elevance Health, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $199.12B +12.5% |
$177.01B +3.3% |
$171.34B +9.4% |
$156.59B +13.0% |
$138.64B +13.8% |
$121.87B +16.9% |
| Net Income | $5.66B -5.3% |
$5.98B -0.1% |
$5.99B +1.6% |
$5.89B -4.3% |
$6.16B +34.7% |
$4.57B -4.9% |
| Diluted EPS | $25.21 -1.8% |
$25.68 +1.8% |
$25.22 +3.9% |
$24.28 -2.7% |
$24.95 +38.8% |
$17.98 -2.7% |
| Total Assets | $121.49B +3.9% |
$116.89B +7.3% |
$108.93B +6.0% |
$102.75B +5.4% |
$97.46B +12.5% |
$86.61B +11.8% |
| Cash and Equivalents | $9.49B +14.5% |
$8.29B +27.0% |
$6.53B -11.7% |
$7.39B +51.4% |
$4.88B -15.0% |
$5.74B +16.3% |
| Long-Term Debt | $30.80B +5.4% |
$29.22B +25.7% |
$23.25B +4.0% |
$22.35B +5.6% |
$21.16B +9.4% |
$19.34B +8.7% |
| Stockholders Equity | $43.88B +6.2% |
$41.31B +5.1% |
$39.31B +8.5% |
$36.24B +0.5% |
$36.06B +8.6% |
$33.20B +4.6% |
| Shares Outstanding | 220.72M -3.0% |
227.48M -2.4% |
233.07M -2.1% |
237.96M -1.6% |
241.77M -1.5% |
245.40M -3.0% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $50.71B | +12.4% | +1.9% |
| Net Income | September 30, 2025 | $1.19B | +17.0% | -31.8% |
| Diluted EPS | September 30, 2025 | $5.32 | +22.0% | -31.1% |
| Total Assets | September 30, 2025 | $122.75B | +5.3% | +0.7% |
| Cash and Equivalents | September 30, 2025 | $8.71B | +10.8% | +1.8% |
| Long-Term Debt | September 30, 2025 | $31.17B | +26.3% | +10.6% |
| Stockholders Equity | September 30, 2025 | $43.95B | +0.4% | +0.5% |
| Shares Outstanding | September 30, 2025 | 222.04M | -4.3% | -1.2% |
- Elevance Health, Inc. reported Total Revenue of $199.12 billion for fiscal year 2025.
- Elevance Health, Inc. showed an increase of +12.5% in Total Revenue compared to the prior fiscal year.
- Elevance Health, Inc. reported Net Income of $5.66 billion for fiscal year 2025.
- Elevance Health, Inc. showed a decrease of -5.3% in Net Income compared to the prior fiscal year.
- Elevance Health, Inc. reported Diluted EPS of $25.21 per share for fiscal year 2025.
- Elevance Health, Inc. showed a decrease of -1.8% in Diluted EPS compared to the prior fiscal year.
- Elevance Health, Inc. reported Total Assets of $121.49 billion for fiscal year 2025.
- Elevance Health, Inc. showed an increase of +3.9% in Total Assets compared to the prior fiscal year.
- Elevance Health, Inc. reported Cash and Equivalents of $9.49 billion for fiscal year 2025.
- Elevance Health, Inc. showed an increase of +14.5% in Cash and Equivalents compared to the prior fiscal year.
- Elevance Health, Inc. reported Long-Term Debt of $30.80 billion for fiscal year 2025.
- Elevance Health, Inc. showed an increase of +5.4% in Long-Term Debt compared to the prior fiscal year.
- Elevance Health, Inc. reported Stockholders Equity of $43.88 billion for fiscal year 2025.
- Elevance Health, Inc. showed an increase of +6.2% in Stockholders Equity compared to the prior fiscal year.
- Elevance Health, Inc. reported Shares Outstanding of 220.72 million shares for fiscal year 2025.
- Elevance Health, Inc. showed a decrease of -3.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: